Search

Search Results
Results 17021 - 17030 of 17223 for Active treatment
  • Panadol Sinus Relief Original Formula
    Drug - 4 Nov 2025
    Consumer Medicine Information (CMI) about Panadol Sinus Relief Original Formula intended for persons living in Australia.
  • Panadol Allergy Sinus
    Drug - 4 Nov 2025
    Consumer Medicine Information (CMI) about Panadol Allergy Sinus intended for persons living in Australia.
  • Patanol
    Drug - 2 Nov 2025
    Consumer Medicine Information (CMI) about Patanol intended for persons living in Australia.
  • H-B-VAX II
    Drug - 2 Nov 2025
    Consumer Medicine Information (CMI) about H-B-VAX II intended for persons living in Australia.
  • Pentasa Tablets
    Drug - 2 Nov 2025
    Consumer Medicine Information (CMI) about Pentasa Tablets intended for persons living in Australia.
  • Pentasa Suppositories
    Drug - 2 Nov 2025
    Consumer Medicine Information (CMI) about Pentasa Suppositories intended for persons living in Australia.
  • Pentasa Sachets
    Drug - 2 Nov 2025
    Consumer Medicine Information (CMI) about Pentasa Sachets intended for persons living in Australia.
  • Improving sample preparation for LC-MS/MS analysis
    White Paper - 28 Oct 2025
    Learn how to optimize sample preparation to minimize ion suppression and improve LC-MS/MS analytical results.
  • Monitoring toxic tropane alkaloids in herbal teas
    White Paper - 28 Oct 2025
    Gain insights into tropane alkaloids analysis in herbal teas with efficient SPE and HPLC-MS/MS for contamination control.
  • Maxidex
    Drug - 27 Oct 2025
    Consumer Medicine Information (CMI) about Maxidex intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback